CARBIDOPA AND LEVODOPA

Parkinson's Agent

Brand names: Carbidopa and Levodopa

Oral

Mechanism of Action

Mechanism of Action Parkinson’s disease is a progressive, neurodegenerative disorder of the extrapyramidal nervous system affecting the mobility and control of the skeletal muscular system. Its characteristic features include resting tremor, rigidity, and bradykinetic movements. Symptomatic treatments, such as levodopa therapies, may permit the patient better mobility. Current evidence indicates that symptoms of Parkinson’s disease are related to depletion of dopamine in the corpus striatum. Administration of dopamine is ineffective in the treatment of Parkinson’s disease apparently because it does not cross the blood-brain barrier. However, levodopa, the metabolic precursor of dopamine, does cross the blood-brain barrier, and presumably is converted to dopamine in the brain. This is thought to be the mechanism whereby levodopa relieves symptoms of Parkinson’s disease.

Indications

INDICATIONS AND USAGE Carbidopa and levodopa extended-release tablets are indicated in the treatment of Parkinson’s disease

post-encephalitic parkinsonism

and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.

FDA Warnings

WARNINGS When patients are receiving levodopa without a decarboxylase inhibitor, levodopa must be discontinued at least twelve hours before carbidopa and levodopa extended-release is started
Falling Asleep During Activities of Daily Living and Somnolence Patients taking carbidopa and levodopa extended-release alone or with other dopaminergic drugs have reported suddenly falling asleep without prior warning of sleepiness while engaged in activities of daily living (includes operation of motor vehicles)
Although many patients reported somnolence while on dopaminergic medications, there have been reports of road traffic accidents attributed to sudden onset of sleep in which the patient did not perceive any warning signs, such as excessive drowsiness, and believed that they were alert immediately prior to the event
Before initiating treatment with carbidopa and levodopa extended-release, advise patients about the potential to develop drowsiness and ask specifically about factors that may increase the risk for somnolence with carbidopa and levodopa extended-release such as the use of concomitant sedating medications and the presence of sleep disorders

Known Side Effects

9 documented side effects by frequency

Falls

>10%

Drug Not Working

>10%

Tremor

1-10%

Dizziness

1-10%

Nausea

1-10%

Fatigue

1-10%

Drowsiness

0.1-1%

Weakness

0.1-1%

UTI

0.1-1%

Community Discussions

2 Reddit threads analysed for CARBIDOPA AND LEVODOPA

Overall Sentiment

Mixed

Comparison Threads

Avg Post Score

2 upvotes

Most discussed side effects in community

Anxiety (2)

Stomach Pain (2)

Itching (1)

Patient Experiences (r/pharmacy, r/AskDocs & more)

Parkinson's Treatments and Symptoms Help

Hello! Been awhile since I posted, but this reddit has also one of the greatest interim helps compared to some of the doctors I've visited. I just want to thank the docs ahead of time <3 33 male, 6 foot, 230 pounds Over the past few months (since late Jan), I've been oversalivating, difficulty sw

r/AskDocs234y ago

Anxiety

Stomach Pain

Itching

Please help diagnose - neuropathy

Help! Progressive neurological syndrome in 69M — possible MSA. Hello, I’m seeking advice regarding my 69-year-old father with progressive neurological symptoms since 2018. Aftet extensive testing, a second neurologist said it's almost certain it's MSA. **Patient:** * Male, 69 y/o * Onset: Feb 2018 *

r/AskDocs219mo ago

Anxiety

Stomach Pain

Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.

Compare With

10 available comparisons

Formulations

Dosage Forms

Tablet

Route

Oral